Nantong, Jiangsu Province, China
Merck will begin building a $108 million pharmaceutical manufacturing facility in China in 2014. Located in the BioSpark development in Nantong, the 430,560-sf building will meet stringent international quality standards for the production of therapeutics. The highly efficient facility will be designed to minimize waste during the manufacturing process. Completion is expected in 2016 with commercial operations commencing in 2017.
Source
